Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31609 | 121 | 33.3 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MACC1 | Author keyword | 55 | 82% | 26% | 32 |
2 | METASTASIS ASSOCIATED IN COLON CANCER 1 | Author keyword | 30 | 84% | 13% | 16 |
3 | MACC 1 | Author keyword | 6 | 100% | 3% | 4 |
4 | SASH1 | Author keyword | 5 | 63% | 4% | 5 |
5 | DISCIPLINES INORGAN MAT CATALYSIS | Address | 3 | 60% | 2% | 3 |
6 | THER EUT LIVER CANC | Address | 1 | 33% | 2% | 2 |
7 | 6Q243 | Author keyword | 1 | 50% | 1% | 1 |
8 | ASTROCYTOMA WHO GRADE II | Author keyword | 1 | 50% | 1% | 1 |
9 | BEIJING CANC HOSP GASTROINTESTINAL SU | Address | 1 | 50% | 1% | 1 |
10 | CNRS UMR 8200 | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MACC1 | 55 | 82% | 26% | 32 | Search MACC1 | Search MACC1 |
2 | METASTASIS ASSOCIATED IN COLON CANCER 1 | 30 | 84% | 13% | 16 | Search METASTASIS+ASSOCIATED+IN+COLON+CANCER+1 | Search METASTASIS+ASSOCIATED+IN+COLON+CANCER+1 |
3 | MACC 1 | 6 | 100% | 3% | 4 | Search MACC+1 | Search MACC+1 |
4 | SASH1 | 5 | 63% | 4% | 5 | Search SASH1 | Search SASH1 |
5 | 6Q243 | 1 | 50% | 1% | 1 | Search 6Q243 | Search 6Q243 |
6 | ASTROCYTOMA WHO GRADE II | 1 | 50% | 1% | 1 | Search ASTROCYTOMA+WHO+GRADE+II | Search ASTROCYTOMA+WHO+GRADE+II |
7 | MAP KINASE SIGNALING CASCADES | 1 | 50% | 1% | 1 | Search MAP+KINASE+SIGNALING+CASCADES | Search MAP+KINASE+SIGNALING+CASCADES |
8 | MEPBA RELEASE | 1 | 50% | 1% | 1 | Search MEPBA+RELEASE | Search MEPBA+RELEASE |
9 | SIGNALING ADAPTOR PROTEIN | 1 | 50% | 1% | 1 | Search SIGNALING+ADAPTOR+PROTEIN | Search SIGNALING+ADAPTOR+PROTEIN |
10 | MELANOCYTE MIGRATION | 0 | 33% | 1% | 1 | Search MELANOCYTE+MIGRATION | Search MELANOCYTE+MIGRATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MACC1 | 15 | 77% | 8% | 10 |
2 | HACS1 | 1 | 100% | 2% | 2 |
3 | BELIEF NETWORK MODEL | 1 | 50% | 1% | 1 |
4 | INDIVIDUALIZED PREDICTION | 1 | 50% | 1% | 1 |
5 | PRIMARY COLON CANCER | 1 | 16% | 2% | 3 |
6 | ADAPTER HACS1 | 0 | 33% | 1% | 1 |
7 | MSIN3 COREPRESSOR COMPLEX | 0 | 33% | 1% | 1 |
8 | C EPSILON TRANSCRIPTION | 0 | 25% | 1% | 1 |
9 | GAB | 0 | 25% | 1% | 1 |
10 | POLYMER SILICA HYBRID NANOCOMPOSITES | 0 | 25% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
MACC1-a novel target for solid cancers | 2013 | 9 | 55 | 51% |
Prognostic Value of MACC1 in Digestive System Neoplasms: A Systematic Review and Meta-Analysis | 2015 | 0 | 29 | 76% |
Future Directions for the Early Detection of Colorectal Cancer Recurrence | 2014 | 7 | 48 | 17% |
Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis | 2015 | 0 | 20 | 55% |
MACC1-more than metastasis? Facts and predictions about a novel gene | 2010 | 20 | 26 | 12% |
Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer | 2009 | 26 | 25 | 4% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DISCIPLINES INORGAN MAT CATALYSIS | 3 | 60% | 2.5% | 3 |
2 | THER EUT LIVER CANC | 1 | 33% | 1.7% | 2 |
3 | BEIJING CANC HOSP GASTROINTESTINAL SU | 1 | 50% | 0.8% | 1 |
4 | CNRS UMR 8200 | 1 | 50% | 0.8% | 1 |
5 | LISHUI CITY CENT HOSP | 1 | 50% | 0.8% | 1 |
6 | PEDIAT PEDIAT INFECTIOL IMMUNOL 1 | 1 | 50% | 0.8% | 1 |
7 | ROBERT ROSSLE CANC HOSP | 1 | 50% | 0.8% | 1 |
8 | SHANGHAI PEOPLES BRANCH HOSP 1 | 1 | 50% | 0.8% | 1 |
9 | KIIT BIOTECHNOL | 1 | 13% | 3.3% | 4 |
10 | BEIJING CANC HOSP TISSUE BANK | 0 | 33% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000127401 | HEPATOCYTE GROWTH FACTOR//C MET//HGF |
2 | 0.0000120354 | NEMO LIKE KINASE//NLK//ZFX |
3 | 0.0000076061 | KIAA1199//MIR 188 5P//TRANSCRIPTOMIC PROFILES |
4 | 0.0000055377 | GRHL2//GRAINYHEAD//GRAINY HEAD |
5 | 0.0000053949 | C7ORF24//GAMMA GLUTAMYL CYCLOTRANSFERASE//HEPATITIS C VIRUS ASSOCIATED LIVER CIRRHOSIS |
6 | 0.0000052448 | DYSCHROMATOSIS SYMMETRICA HEREDITARIA//DOWLING DEGOS DISEASE//DSRAD GENE |
7 | 0.0000052251 | CSE1L//PHOSPHO CSE1L//CELLULAR APOPTOSIS SUSCEPTIBILITY |
8 | 0.0000052217 | INTER SIMPLE SEQUENCE REPEAT PCR//BIOPHYS CYTOMETRY//HOSP UNIV SALAMANCA IBSAL |
9 | 0.0000043080 | INCIDENCE ESTIMATES//MED LIBERAL ARTS SCI//GUAM CANC REGISTRY |
10 | 0.0000040572 | ASIAN CANCER CONTROL//BUR HLTH TECHNOL RD PLANNING BUDGET MANAGEMENT//EARLY DETECT PREVENT |